| 标题 |
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup Analysis |
| 网址 | |
| DOI |
10.1159/000548300
doi
|
| 其它 |
期刊:Liver Cancer 作者:Masatoshi Kudo; Atsushi Hiraoka; Kazushi Numata; Tatsuya Yamashita; Masayuki Kurosaki; et al 出版日期:2025-09-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)